GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>Is this a trick question???<

No, not at all. I fail to see why you and other posters think that GTC’s relationship with downstream-processing contractors is a big deal.

The salient points as far as I can tell are:

1. It is more cost-effective for GTC to outsource fill/finish than to build an in-house operation.

2. There are several contractors capable of meeting GTC’s downstream-processing needs, which allows GTC to shop for the best deal.

In other words, this is an aspect of GTC’s business that I take for granted. The only time I consider it worthy of note is when something changes or goes wrong.